IP Library Granted Patent US 6,878,831
Granted Patent B2
US 6,878,831 · App. 10/451,723 · Granted Apr 12, 2005

Process for preparing optically active 2,3-dihydrobenzofuran compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,878,831
App. No.
10/451,723
Granted
Apr 12, 2005
Kind
B2
Abstract

A process for preparing optically active 2,3-dihydrobenzofuran compounds which comprises subjecting a 2,3-dihydrobenzofuran compound represented by the general formula or a salt thereof to optical resolution with an optically active acid compound: [wherein R 1 and R 2 are each hydrogen or an optionally substituted hydrocarbon group; R 3 is an optionally substituted aromatic group; and C is a benzene ring which may further have a substituent in addition to the amino group]. The process enables industrially advantageous production of intermediates for the synthesis of optically active 2,3-dihydrobenzofuran compounds useful as preventive and/or therapeutic drugs for neurodegenerative diseases and so on.

Claims (23)

1. A process for producing an optically active 2,3-dihydrobenzofuran compound or a salt thereof, comprising optically resolving a 2,3-dihydrobenzofuran compound represented by the formula:

wherein R 1 and R 2 are each a hydrogen atom or an optionally substituted hydrocarbon group, R 3 is an optionally substituted aromatic group, ring C is a benzene ring optionally having a substituent besides the amino group or a salt thereof, with an optically active acidic compound.

2. The process according to claim 1 , wherein R 1 and R 2 are each a C 1-6 alkyl group.

3. The process according to claim 1 , wherein R 3 is a phenyl group optionally having C 1-6 alkyl and/or halogen atom.

4. The process according to claim 1 , wherein the ring C is a benzene ring fully substituted with the substituents selected from a C 1-6 alkyl, a C 1-6 alkoxy and a C 1-3 alkylenedioxy besides the amino group.

5. The process according to claim 1 , wherein the compound represented formula (I) or a salt thereof is a compound represented by the formula:

wherein R 1′ and R 2′ are each a C 1-6 alkyl group, R 3′ is a phenyl group optionally having C 1-6 alkyl and/or halogen atom, R 4 , R 5 and R 6 are each a C 1-6 alkyl, a C 1-6 alkoxy or a C 1-3 alkylenedioxy, or a salt thereof.

6. The process according to claim 1 , wherein the optically active acidic compound is an optically active O,O′-diacyltartaric acid derivative.

7. The process according to claim 1 , wherein the optically active acidic compound is an optically active N-acylamino acid derivative.

8. The process according to claim 1 , wherein the optically active acidic compound is an optically active phosphoric acid derivative represented by the formula:

wherein Ar is an optionally substituted aromatic hydrocarbon group, R 1a and R 2a are each a hydrogen atom, an optionally substituted lower alkyl group, an optionally substituted lower alkoxy group, a halogen atom or a nitro group, or R 1a and R 2a may be bound together to form an optionally substituted alkylene group or an optionally substituted methylenedioxy, and the symbol * shows the position of an asymmetric carbon.

9. The process according to claim 1 , wherein the optically active acidic compound is an optically active O,O′-di-(p-toluoyl)tartaric acid.

10. The process according to claim 1 , wherein the optically active acidic compound is an optically active N-(3,5-dinitrobenzoyl)-α-phenylglycine.

11. The process according to claim 8 , wherein the phosphoric acid derivative represented by the formula (II) is an optically active compound of 2-hydroxy-5,5-dimethyl-4-(1-naphthyl)-1,3,2-dioxaphosphorinane 2-oxide.

12. The process according to claim 5 , wherein R 4 , R 5 and R 6 are each a methyl group.

13. A salt of a compound represented by the formula (I′):

wherein R 1′ and R 2′ are each a C 1-6 alkyl group, R 3′ is a phenyl group optionally having C 1-6 alkyl and/or halogen atom, R 4 , R 5 and R 6 are each a C 1-6 alkyl, a C 1-6 alkoxy or a C 1-3 alkylenedioxy

with an optically active O,O′-di-(p-toluoyl)tartaric acid, an optically active N-(3,5-dinitrobenzoyl)-α-phenylglycine or an optically active 2-hydroxy-5 ,5-dimethyl-4-(1-naphthyl)-1,3,2-dioxaphosphorinane 2-oxide.

14. A salt of (R)-(+)-2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-amine with (2S,3S)-O,O′-di-(p-toluoyl)tartaric acid.

15. A salt of (+)-2,2,4,6,7-pentamethyl-3-[4-(1-methylethyl)phenyl]-2,3-dihydro-1-benzofuran-5-amine with (2S,3S)-O,O′-di-(p-toluoyl)tartaric acid.

16. A salt of (+)-2,2,4,6,7-pentamethyl-3-[4-(1-methylethyl)phenyl]-2,3-dihydro-1-benzofuran-5-amine with (S)-N-(3,5-dinitrobenzoyl)-α-phenylglycine.

17. A salt of (+)-2,2,4,6,7-pentamethyl-3-[4-(1-methylethyl)phenyl]-2,3-dihydro-1-benzofuran-5-amine with (+)-2-hydroxy-5,5-dimethyl-4-(1-naphthyl)-1,3,2-dioxaphosphorinane 2-oxide.

18. A salt of (+)-2,2,4,6,7-pentamethyl-3-(4-bromophenyl)-2,3-dihydro-1-benzofuran-5-amine with (2S,3S)-O,O′-di-(p-toluoyl)tartaric acid.

Assignments (2)
CHANGE OF NAME Recorded May 16, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016891/0046 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2003
From: AOKI, ISAO; ADACHI, MARI; TAWADA, HIROYUKI; YAMASHITA, MAKOTO; SERA, MISAYO
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 014654/0651 →